Biorab Market Report 2026

Biorab Market Overview

• The Biorab market growth in the historic period has been driven by global rabies control initiatives, proven efficacy of rabies biologics • Market expansion is supported by expansion of rabies elimination goals, rising public health funding • Growth Driver: Rising Rabies Incidence Drives Growth Of The Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Biorab Market?

Biorab is a medication used to treat acid-related conditions such as acid reflux, peptic ulcer disease, and Zollinger-Ellison syndrome by reducing stomach acid production. It helps alleviate symptoms, promote healing of ulcers, and prevent further complications from excessive acid secretion. The main types of indications in biorab are pre-exposure prophylaxis and post-exposure prophylaxis of rabies. Pre-exposure prophylaxis (PrEP) refers to a preventive strategy in which individuals at high risk for HIV infection take medication to reduce the likelihood of becoming infected with the virus. It is distributed through hospitals and clinics, retail pharmacies, online pharmacies, and public health programs for various end users, including geriatric, pediatric, and veterinary use.

What Is The Biorab Market Growth Forecast?

The growth in the forecast period can be attributed to expansion of rabies elimination goals, rising public health funding, improved rural healthcare access, growth in emergency care infrastructure, increased surveillance of zoonotic diseases. Major trends in the forecast period include growing focus on rabies prevention programs, rising demand for post exposure prophylaxis, expansion of public health vaccination initiatives, improved access to anti rabies biologics, strengthening emergency infectious disease response.

Global Biorab Market Segmentation

1) By Indication: Pre-Exposure Prophylaxis, Post-Exposure Prophylaxis Of Rabies 2) By Distribution Channel: Hospitals And Clinics, Retail Pharmacies, Online Pharmacies, Public Health Programs 3) By End User: Geriatric, Pediatric, Veterinary Use

What Are The Drivers Of The Biorab Market?

The rising incidence of rabies is expected to drive the growth of the biorab market going forward. Rabies refers to a viral disease that affects the central nervous system (CNS) and is caused by the rabies virus, which belongs to the Rhabdoviridae family. The rising incidence of rabies is due to increased stray dog populations, which are often unvaccinated and serve as key transmitters, along with limited access to post-exposure prophylaxis (PEP) in rural areas, hindering timely treatment. Biorab helps reduce rabies transmission and fatalities by offering effective post-exposure prophylaxis and supporting vaccination programs, especially in areas with limited healthcare access. For instance, in April 2024, according to a report published by the South Dakota Department of Health, a US-based governmental agency, in 2023, South Dakota saw a 122% increase in rabies cases, with 20 animals testing positive, compared to just 9 in 2022. Therefore, the rising incidence of rabies is expected to propel the growth of the biorab industry. The growing geriatric population is expected to boost the growth of the biorab market. The geriatric population refers to individuals who are aged 65 years and older, a group that typically experiences age-related health conditions and requires specific healthcare services. The growing geriatric population is due to increased life expectancy, advancements in healthcare, improved living conditions, and a decline in birth rates over the years. Biorab supports geriatric patients by offering specialized healthcare solutions that address age-related challenges, improve disease management, and enhance overall quality of life through tailored diagnostics and therapies. For instance, in May 2024, according to the Administration for Community Living, a US-based government agency, in 2022, 17.3% of the population was 65 or older. This percentage is expected to increase to 22% by 2040. Therefore, the growing geriatric population drives the biorab industry. The increasing research and development activities are expected to drive the growth of the biorab market. Research and development activities involve the systematic exploration and development of new knowledge, products, or technologies through research and experimentation. Research and development activities are increasing due to the growing demand for innovative solutions to address emerging health threats and improve treatment efficacy. Research and development activities enhance biorab by driving innovations in rabies prevention and treatment, making it more effective for high-risk populations. They improve vaccine efficacy and safety profiles, supporting wider adoption and better public health outcomes. For instance, in July 2025, according to Eurostat, a Luxembourg-based statistical agency, the total government budget allocations for research and development across the EU reached an estimated €127,916 million in 2024, marking a 3.4% increase compared with €123,675 million in 2023. Therefore, the increasing research and development activities are driving the growth of the biorab industry.

Key Players In The Global Biorab Market

Major companies operating in the biorab market are Vowcare Products Pvt. Ltd., Bioethics Lifesciences Pvt. Ltd.

Regional Insights

North America was the largest region in the biorab market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Biorab Market?

The biorab market consists of sales of products including omeprazole, lansoprazole, and esomeprazole. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Biorab Market Report 2026?

The biorab market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the biorab industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.